Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD37 is a cell surface glycoprotein and a member of the tetraspanin (transmembrane 4 superfamily) protein family. It is highly expressed on mature B cells and plays a key role in immune regulation, including cell development, activation, growth, motility, and humoral/cellular immune responses. CD37 forms complexes with integrins and other tetraspanins to create tetraspanin-enriched microdomains (TEMs). It has been implicated in diseases such as Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma, where patients lacking CD37 have worse clinical outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD37.